Info

Vous avez renseigné l'adresse d'un site internet Kleresca® qui n'est pas celui de votre pays d'origine. Veuillez noter que les informations disponibles sur ce site peuvent ne pas être applicables pour votre pays.

Creation or Destruction?

Which would you choose for your skin? For us, the choice is easy. 
If you had a choice between breaking down or building up your skin, which would you choose? We think we know the answer. Dealing with rosacea often means dealing with sensitive skin, and the last thing sensitive skin wants is a harsh product or procedure.
This reality can be tough because a lot of treatments available can be painful, may require some sort of prescription drug, or simply don’t work for you. 
One of the best parts of Kleresca® Rosacea Treatment is it works to improve microvascularisation, which is basically the creation of more blood vessels. If you’re thinking, “Hmm yeah, that’s the last thing I want from a rosacea treatment”, hear us out:
 

Improving microvascularisation creates more fine blood vessels. More vessels equal better blood flow. More blood flow equals less visible blood vessels. So, what does that mean for your skin? Well, a few things:

1. Reduced redness and flushing
2. Less burning and stinging 
3. Overall, less stress in your skin

At Kleresca® we don’t believe in destruction. What we do believe in is building up your skin’s own repair mechanisms through fluorescent light energy and ensuring our treatment is suitable for highly sensitive skin. Our ultimate goal? Helping you feel good about your skin. And how do we do that? No cell destruction, and no painful shortcuts.

 

Follow us on our social media channels to stay up to date with our latest news, real-life results stories, and breakthrough scientific advancements in treating skin. 

      
        


 




Sources

Braun, S.A.& Gerber, P. A photoconverter -gel assisted blue light therapy for the treatment of rosacea. Int. K Dermatol. 2017 [Epub ahead of print]
Nielsen, Schoedt & Bak-Christensen. Clinical Evaluation – Kleresca® Biophotonic Treatments. 2017. Kleresca® Data on File
J. Spoendlin, J. J. Voegel, S. S. Jick, C. R. Meier. (2012, September). A study on the epidemiology of rosacea in the U.K. British Journal of Dermatology, 167(3), 598-605.
National Rosacea Society. (2018). Rosacea Now Estimated to Affect at Least 16 Million Americans. Retrieved January 31, 2018, from www.rosacea.org: https://www.rosacea.org/rr/2010/winter/article_1.php 
 

Is Early Diagnosis of Rosacea Really That Important?

Understanding your body is powerful. So, when your skin gives you a sign that something is not right, you should listen.
Kleresca® utilise des cookies afin de vous offrir la meilleure expérience en ligne et de fournir des données combinées et anonymisées sur l'utilisation du site. En cliquant sur « Oui, j'accepte », vous consentez à cette utilisation de cookies. Vous pouvez savoir quels cookies nous utilisons, leur rôle et comment les désactiver dans notre Politique en matière de cookies. Vous pouvez trouver plus d'informations à ce sujet dans notre Politique de confidentialité